The Center for Comparative Medicine’s Mission embraces the concept of “One Medicine” through interdisciplinary comparative medical research, teaching, and model development. Its research mission is to investigate the pathogenesis of human disease, using experimental animal models and naturally occurring animal diseases. CCM research programs facilitate its teaching mission of comparative medical training at the professional, graduate and post-graduate levels. CCM faculty expertise and programs in integrative biology provide animal model development, validation, and collaborative support to the general scientific community.

Latest News 

NIH_logo Chris Miller, PhD Awarded a 5-year, $3.3 Million, NIH Research Project (R01) grant (6/25/2015) - Dr. Chris Miller was recently awarded a five year, $3.3 million, NIH Research Project (R01) grant, R01 AI118590 titled “How did a Vaccine Enhance HIV Acquisition?” This project seeks to understand how an Ad5 vectored HIV vaccine used in a STEP trial increased HIV infections and will provide us with valuable information that will help […]
kcra Dr. Peter Barry­ television coverage of CMV research (5/18/2015) - Dr. Peter Barry did an outstanding job informing the public of the translational importance of his CMV research on KCRA, Sunday May 17.  The CCM is committed to finding solutions to critical health problems such as CMV, the “birth defect virus”.   To learn more about Dr. Peter Barry’s program, please visit
NIH_logo K.C. Kent Lloyd, DVM, PhD Awarded MMRRC Competitive Renewal (3/2/2015) - Dr. K.C. Kent Lloyd was recently awarded a five year, $6.5 million, competitive renewal of the NIH Mutant Mouse Regional Resource Center (MMRRC) grant, U42OD012210.   The MMRRC National Consortium serves a primary role in ensuring that valuable mouse models of human disease, development, and behavioral abnormalities created in research laboratories are shared broadly among the biomedical […]
pfizer_proc_pos Peter A. Barry, PhD Awarded a New $1.2 Million Dollar Pfizer Contract (2/27/2015) - Dr. Peter A. Barry, PhD was recently awarded a new $1.2 million dollar Pfizer contract to work on the “Immunogenicity of hCMV recombinant gB and pentameric complex proteins in rhCMV-seronegative rhesus macaques at UC Davis”.  For more information on Dr. Barry’s research please visit his research site at
barry, peter Peter A. Barry, PhD Comments on Scientific American Story (2/18/2015) - Peter A. Barry, PhD was recently quoted in a Scientific American Story, “Your Immune System is Made, Not Born” which offers new insight into the the creation of our immune system.   Dr. Barry’s research program studies cytomegalovirus at the Center for Comparative Medicine.
mcsorley, stephen Stephen J. McSorley, PhD Elected to Fellowship in the American Academy of Microbiology (2/18/2015) - Stephen J. McSorley, PhD, was elected to Fellowship in the American Academy of Microbiology.  The Academy, the honorific leadership group within the American Society for Microbiology, recognizes excellence, originality, and leadership in the the microbiological sciences.  Congratulations Dr. McSorley!

CCM Seminar Series


Recent insights into multiple sclerosis epidemiology: from cancer to drug effectiveness and the gut microbiome

June 30 @ 12:00 pm - 1:00 pm

Helen Tremlett, PhD, Associate Professor, Division of Neurology Canada Research Chair, Neuroepidemiology and Multiple Sclerosis, University of British Columbia